The TRANSPLANTEX initiative

Hum Immunol. 2016 Nov;77(11):1005-1007. doi: 10.1016/j.humimm.2016.10.016.


TRANSPLANTEX, a French "investment for the future" initiated consortium of leading transplant units and research laboratories across France and a number of European countries aims to unravel, through mainly high-throughput genomics (and other omics) analyses of donor and recipients, novel (a) non-HLA, histocompatibility antigens, whether inside, or outside the MHC; (b) pre/post transplantation biomarkers. This shall lead to our better understanding of the pathophysiology of (and eventually designing better therapeutics for) the graft-versus-host disease in hematopoietic cell transplants and that of chronic graft rejection after kidney transplant. Industrial developments as well as innovative teaching initiatives are also integral part of this program. The present issue of Human Immunology aims to present a first snapshot of some of the research performed by TRANPLANTEX partners.

Publication types

  • Editorial

MeSH terms

  • Biomarkers / metabolism
  • Consensus
  • France
  • Graft Rejection / diagnosis
  • Graft Rejection / prevention & control*
  • Graft vs Host Disease / diagnosis
  • Graft vs Host Disease / therapy*
  • Histocompatibility Testing*
  • Humans
  • Immunosuppression Therapy*
  • Kidney Transplantation*
  • Registries


  • Biomarkers